Otnox
LVLatvia·Buyer: Pharmidea

Pharmacokinetic (PK) biosimilarity and bioanalytical research study for a generic medicinal product intended for the treatment of diabetes.

Contract signed·29 May 2026·EUR 700,000

Otnox Intelligence Summary

Published

29.05.2026

Līgums noslēgts

29.05.2026

Deadline

15.06.2026

Rezultāts

29.06.2026

See full tender intelligence

All winners, buyer history, related tenders and AI insights.

© 2026 SIA «Vietne». All rights reserved.